Institute for nanoscience and nanotechnology, Sharif University of Technology, Tehran, 14588-89694, Iran.
Stem Cell Technology Research Centre, Tehran, 19977-75555, Iran.
Sci Rep. 2017 Mar 15;7(1):194. doi: 10.1038/s41598-017-00268-8.
In this study, a hybrid magnetic-DNA directed immobilisation approach is presented to enhance protein capture and detection on a microfluidic platform. DNA-modified magnetic nanoparticles are added in a solution to capture fluorescently labelled immunocomplexes to be detected optically. A magnetic set-up composed of cubic permanent magnets and a microchannel was designed and implemented based on finite element analysis results to efficiently concentrate the nanoparticles only over a defined area of the microchannel as the sensing zone. This in turn, led to the fluorescence emission localisation and the searching area reduction. Also, compared to processes in which the immunocomplex is formed directly on the surface, the proposed approach provides a lower steric hindrance, higher mass transfer, lower equilibrium time, and more surface concentration of the captured targets leading to a faster and more sensitive detection. As a proof-of-concept, the set-up is capable of detecting prostate-specific membrane antigen with concentrations down to 0.7 nM. Our findings suggest that the approach holds a great promise for applications in clinical assays and disease diagnosis.
在这项研究中,提出了一种混合磁-DNA 定向固定化方法,以增强微流控平台上的蛋白质捕获和检测。将 DNA 修饰的磁性纳米粒子添加到溶液中,以光学方式捕获荧光标记的免疫复合物。根据有限元分析结果,设计并实现了由立方永磁体和微通道组成的磁装置,以有效地仅在微通道的定义区域(即传感区)集中纳米粒子。这反过来又导致了荧光发射的定位和搜索区域的缩小。此外,与直接在表面上形成免疫复合物的过程相比,所提出的方法提供了更低的空间位阻、更高的传质、更短的平衡时间和更高的捕获目标表面浓度,从而实现更快、更灵敏的检测。作为概念验证,该装置能够检测到浓度低至 0.7nm 的前列腺特异性膜抗原。我们的研究结果表明,该方法在临床分析和疾病诊断中的应用具有很大的前景。